These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8608659

  • 1. Beta 2-microglobulin amyloidosis: why and how to look for it.
    Schaeffer J, Ehlerding G, Flöge J, Koch KM, Shaldon S.
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S3-9. PubMed ID: 8608659
    [Abstract] [Full Text] [Related]

  • 2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT, Williams AW, Johnson WJ.
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [Abstract] [Full Text] [Related]

  • 3. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W, Szepietowski T.
    Postepy Hig Med Dosw; 1992 Apr; 46(2):209-38. PubMed ID: 1470582
    [Abstract] [Full Text] [Related]

  • 4. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J, Floege J, Ehlerding G, Koch KM.
    Nephrol Dial Transplant; 1995 Apr; 10 Suppl 3():4-8. PubMed ID: 7494614
    [Abstract] [Full Text] [Related]

  • 5. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J, Schäffer J, Koch KM, Shaldon S.
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [Abstract] [Full Text] [Related]

  • 6. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G, Sperschneider H, Fünfstück R, Ritz E.
    Nephrol Dial Transplant; 1994 Oct; 9 Suppl 3():48-50. PubMed ID: 8072726
    [Abstract] [Full Text] [Related]

  • 7. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM, Jaber BL.
    Semin Dial; 2006 Oct; 19(2):105-9. PubMed ID: 16551286
    [Abstract] [Full Text] [Related]

  • 8. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F, Homma N, Arakawa M.
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [Abstract] [Full Text] [Related]

  • 9. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A, Gejyo F.
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J.
    Przegl Lek; 2006 Aug; 63(7):567-72. PubMed ID: 17203811
    [Abstract] [Full Text] [Related]

  • 11. Beta-2-microglobulin-associated amyloidosis.
    Floege J, Ehlerding G.
    Nephron; 1996 Aug; 72(1):9-26. PubMed ID: 8903856
    [Abstract] [Full Text] [Related]

  • 12. Extraskeletal problems and amyloid.
    Drüeke TB.
    Kidney Int Suppl; 1999 Dec; 73():S89-93. PubMed ID: 10633472
    [Abstract] [Full Text] [Related]

  • 13. [Diagnosis of and therapy for patients with dialysis amyloidosis].
    Homma N, Gejyo F.
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():348-52. PubMed ID: 15250322
    [No Abstract] [Full Text] [Related]

  • 14. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N, Maruyama H.
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [Abstract] [Full Text] [Related]

  • 15. [Pathogenesis of dialysis amyloidosis].
    Gejyo F, Hasegawa S, Homma N, Maruyama H, Maruyama S, Arakawa M.
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract] [Full Text] [Related]

  • 16. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
    Zingraff J, Beyne P, Ureña P, Uzan M, Nguyen Khoa Man, Descamps-Latscha B, Drüeke T.
    Nephrol Dial Transplant; 1988 Jan; 3(3):284-90. PubMed ID: 3140102
    [Abstract] [Full Text] [Related]

  • 17. Osteoarticular disorders of renal origin: disease-related and iatrogenic.
    Kay J, Bardin T.
    Baillieres Best Pract Res Clin Rheumatol; 2000 Jun; 14(2):285-305. PubMed ID: 10925746
    [Abstract] [Full Text] [Related]

  • 18. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
    Stefanović V, Kostić S, Djordjević V, Mitić M, Bogicević M.
    Perit Dial Int; 1993 Jun; 13 Suppl 2():S520-2. PubMed ID: 8399654
    [Abstract] [Full Text] [Related]

  • 19. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
    Iida Y, Miyata T, Inagi R, Sugiyama S, Maeda K.
    Biochem Biophys Res Commun; 1994 Jun 30; 201(3):1235-41. PubMed ID: 8024566
    [Abstract] [Full Text] [Related]

  • 20. Dialysis-related amyloidosis.
    Manske CL.
    J Lab Clin Med; 1994 Apr 30; 123(4):458-60. PubMed ID: 8144992
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.